Sector Update: Healthcare Shares Lower; Sinovac Surges 10% on Q3 Results

Shutterstock photo

Healthcare stocks:

JNJ: -0.42%

PFE: -0.25%

ABT: flat

MRK: -0.61%

AMGN: -1.52%

Healthcare shares are lower in pre-market, while NPS Pharmaceuticals ( NPSP ) is up about 4% in pre-market trade as it said the U.S. Food and Drug Administration has accepted for review its supplemental new drug application for Gattex for injection to treat short bowel syndrome in adults who are dependent on parenteral support.

And, shares of Sinovac Biotech Ltd. ( SVA ) are up nearly 10% at $6.45 in pre-market after the China-based biopharmaceutical company reported overnight a net income in Q3 2013 on increased sales, driven by the expanded capacity of SVA's fully operational Changping filling and packaging line.

SVA said net income was $2.3 million, or $0.04 per diluted share, compared to a net loss of $3 million, or $0.05 per diluted share, in the same period last year. Sales totaled $22.1 million, up 54.5% from $14.3 million in the prior-year quarter.

No analyst estimates were available for comparison.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Commodities
Referenced Symbols: NPSP , SVA

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by